Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotype-Directed Flecainide vs Sotalol in Atrial Fibrillation
NCT02347111Phase 4Recruiting
- Sponsor
- University of Illinois Chicago
- Start
- Dec 2020
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of flecainide, sotalol in Atrial fibrillation (AFib), sponsored by University of Illinois Chicago. Started Dec 2020; status: recruiting.
02
Drugs
flecainidesotalol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02347111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02347111.